Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
26.92 -0.00    0.00%
19/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  Chile
ISIN:  US7170811035 
  • Volume: 81
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 26.24 - 26.24
Pfizer 26.92 -0.00 0.00%

PFE Balance Sheet

 
Featured here, the Balance Sheet for Pfizer Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
01/10
2023
02/07
2023
02/04
Total Current Assets 43333 74012 73347 50078
Cash and Short Term Investments 12690 44182 44785 19972
Cash - - - -
Cash & Equivalents 2853 3148 2632 2166
Short Term Investments 9837 41033 42153 17806
Total Receivables, Net 15155 15003 13425 15445
Accounts Receivables - Trade, Net 11177 11086 10231 12305
Total Inventory 10189 10204 10310 9541
Prepaid Expenses - - - -
Other Current Assets, Total 5299 4623 4827 5120
Total Assets 226501 215021 220168 195617
Property/Plant/Equipment, Total - Net 21864 17862 17488 17052
Property/Plant/Equipment, Total - Gross 37909 33641 33042 32566
Accumulated Depreciation, Total -16045 -15779 -15554 -15514
Goodwill, Net 67783 51527 51572 51476
Intangibles, Net 64900 40224 41406 42002
Long Term Investments 15382 14113 14945 14628
Note Receivable - Long Term 3978 3917 3194 3140
Other Long Term Assets, Total 11439 8933 13149 13079
Other Assets, Total 11970 49208 52126 24324
Total Current Liabilities 47794 31136 34647 36562
Accounts Payable 6710 5338 6081 6123
Payable/Accrued - - - -
Accrued Expenses 9224 7891 7252 7541
Notes Payable/Short Term Debt 8096 298 420 621
Current Port. of LT Debt/Capital Leases 2797 2254 3580 3567
Other Current liabilities, Total 20967 15355 17314 18710
Total Liabilities 137213 117817 120875 94381
Total Long Term Debt 61813 61581 61674 31978
Long Term Debt 61813 61581 61674 31978
Capital Lease Obligations - - - -
Deferred Income Tax 640 1125 1232 1067
Minority Interest 274 270 274 266
Other Liabilities, Total 18596 23407 22628 23887
Total Equity 89288 97204 99293 101236
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 478 478 478 478
Additional Paid-In Capital 92631 92496 92329 92153
Retained Earnings (Accumulated Deficit) 118353 126411 128796 131102
Treasury Stock - Common -114487 -114485 -114482 -114473
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -7687 -7696 -7828 -8024
Total Liabilities & Shareholders' Equity 226501 215021 220168 195617
Total Common Shares Outstanding 5646 5646 5645 5645
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
MOSHE LION
MOSHE LION 5 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In your opinion it could go back to $40?
ARINSON S
ARINSON S 5 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great entry price to Long
Leo Tim
Leo Tim 21 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
intelligent science beauty technology psychypnotherapeuticlinicanewistech psychypnotherapist intellact far more advanced intellactuallist standard and firm wise decision state of the ART worlds most needed revelation
Donald Lowe
Donald Lowe Apr 25, 2024 12:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So true. Take heart. There's always support at zero. The price per share is now $16.00 less than when he took over as CEO in 2019.
George Galloway
George Galloway Apr 25, 2024 12:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
working hard towards another milestone or better known as another 52 week low
Kevin Lim
Kevin Lim Apr 25, 2024 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell
Kevin Parker
Kevin Parker Apr 09, 2024 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I appreciate what Pfizer does... But where are the cancer vaccines 9ther companies are developing?
Jay Clerk
Jay Clerk Apr 09, 2024 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They make more off treating it then treating the side effectswith more pills to treat the side effects from the pills and so on
Petru Zogo
Petru Zogo Apr 02, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pfizer is in Europe in the middle of a scandal of proportions together with the president Ursula from. EU because of the strange contracts made during the Covid19 epidemic
Joe McKela
Joe McKela Apr 02, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Corruption, bribery, blackmail, the regular big pharma MO.
ali can
ali can Mar 25, 2024 3:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
George Galloway
George Galloway Mar 22, 2024 4:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Leadership has to be removed to regain the trust of investors.
Joe McKela
Joe McKela Mar 22, 2024 4:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No, it is corrupt to its core and huge lawsuits will follow.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email